Journals risk being used in place of regulators when they publish studies of novel vaccines that have not yet been authorised by a major regulator. Chris van Tulleken argues that peer review is inadequate to decide the risk-benefit ratio of new drugs In August 2020 President Vladimir Putin announced Sputnik V, a vaccine developed by Russia’s Gamaleya National Center of Epidemiology and…
Canadians support it, public health demands it, now policy makers must deliver it Canada’s universal healthcare system, often referred to as Medicare, provides universal, public…
NHS England is exploring ways it can reduce the amount of statutory and mandatory training that doctors undertake, to free up clinicians’ time to care…
Drug regulators in several African countries have recalled a batch of Johnson & Johnson children’s cough syrup after officials in Nigeria reported high levels of…
Ministers must do more to anticipate shortages of medicines in the UK, which have become shockingly severe and have become a “new normal” since Brexit,…
After years of underfunding, being undervalued, and issues around pay and working conditions, something finally seems to have changed for doctors. Whisper it softly, but…
The success of NHS Practitioner Health shows that the unique demands of working in healthcare merit a tailored response, says Zaid Al-Najjar “If you build…
Chronically underfunded and with hundreds of thousands of roles vacant, social care is in crisis, piling pressure on frontline services and GPs. One solution comes…
New study identifies a wider range of associated harm The linked study by Mok and colleagues (doi:10.1136/bmj-2023-076268) provides new insights into the risks associated with…
India’s marathon 2024 election process sees several health matters coming to the fore, including universal healthcare, the health workforce, and infrastructure. Kamala Thiagarajan reports When…
The UK has the 12th largest gender health gap in the world. Closing it will require investment, but would also reap rewards for women and…
